GUT MICROBIOTA-DEPENDENT MARKER TMAO IN PROMOTING CARDIOVASCULAR DISEASE: INFLAMMATION MECHANISM, CLINICAL PROGNOSTIC, AND POTENTIAL AS A THERAPEUTIC TARGET